These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21983761)

  • 41. Electroconvulsive therapy in a physically restrained man with comorbid major depression, severe agoraphobia with panic disorder, and histrionic personality disorder.
    Rapinesi C; Serata D; Del Casale A; Kotzalidis GD; Romano S; Milioni M; Capezzuto S; Carbonetti P; Angeletti G; Fensore C; Tatarelli R; Girardi P
    J ECT; 2012 Mar; 28(1):72-3. PubMed ID: 22343590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electroconvulsive therapy and venous angiomas: two case reports and review of the literature.
    Zahedi S; Yang C; O'Hanlon D; Tanev K; Shea WP
    J ECT; 2006 Sep; 22(3):228-30. PubMed ID: 16957543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of patient satisfaction after ultrabrief bifrontal and unilateral electroconvulsive therapies for major depression.
    Sienaert PA; Vansteelandt K; Demyttenaere K; Peuskens J
    J ECT; 2010 Mar; 26(1):55-9. PubMed ID: 19458534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term weekly continuation electroconvulsive therapy: a case series.
    Zisselman MH; Rosenquist PB; Curlik SM
    J ECT; 2007 Dec; 23(4):274-7. PubMed ID: 18090702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy of electroconvulsive therapy and antidepressants in depression.
    Avery D; Winokur G
    Biol Psychiatry; 1977 Aug; 12(4):507-23. PubMed ID: 889984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electroconvulsive therapy-induced migraine successfully treated with valproic acid.
    Rovers JM; Roks G
    J ECT; 2012 Mar; 28(1):64-5. PubMed ID: 22343586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [ECT treatment of Cotard's syndrome in a patient with combined valvular heart disease and persistent atrial fibrillation].
    Kucia K; Delkowski RS
    Wiad Lek; 2004; 57(5-6):290-2. PubMed ID: 15518080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversible ischemic neurologic deficit after ECT.
    Miller AR; Isenberg KE
    J ECT; 1998 Mar; 14(1):42-8. PubMed ID: 9661093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy.
    Tokutsu Y; Umene-Nakano W; Yoshimura R; Katsuki A; Atake K; Nakamura J
    J ECT; 2012 Mar; 28(1):56. PubMed ID: 21778911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?
    Rabheru K
    J ECT; 2012 Mar; 28(1):39-47. PubMed ID: 22330700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement in response times for simple and complex tasks after electroconvulsive therapy.
    Kalb R; Ellinger K; Reulbach U
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):459-65. PubMed ID: 12691781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Open trial on the efficacy of right unilateral electroconvulsive therapy with titration and high charge.
    Rosa MA; Rosa MO; Daltio CS; Abreu LN; Marcolin MA
    J ECT; 2006 Dec; 22(4):237-9. PubMed ID: 17143152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurally mediated syncope in electroconvulsive therapy maintenance.
    Arbaizar B; Llorca J
    J ECT; 2012 Mar; 28(1):66-7. PubMed ID: 22343587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electroconvulsive therapy for frontotemporal dementia with comorbid major depressive disorder.
    Borisovskaya A; Augsburger J; Pascualy M
    J ECT; 2014 Dec; 30(4):e45-6. PubMed ID: 24901427
    [No Abstract]   [Full Text] [Related]  

  • 57. Electroconvulsive therapy (ECT) in a patient with a dual-chamber sensing, VDDR pacemaker.
    Giltay EJ; Kho KH; Keijzer LT; Leijenaar M; van Schaick HW; Blansjaar BA
    J ECT; 2005 Mar; 21(1):35-8. PubMed ID: 15793358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electroconvulsive therapy in a patient with glaucoma.
    Amritwar A; Karia S; De Sousa A; Sonavane S
    Natl Med J India; 2016; 29(2):85-6. PubMed ID: 27586212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electroconvulsive Therapy and All-Cause Mortality in Texas, 1998-2013.
    Dennis NM; Dennis PA; Shafer A; Weiner RD; Husain MM
    J ECT; 2017 Mar; 33(1):22-25. PubMed ID: 27428480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safe and Successful ECT in a Female-to-Male Transgender Individual With Major Depression.
    Coffey MJ; Stevens JR
    J ECT; 2016 Sep; 32(3):e11-2. PubMed ID: 26909826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.